Methylphenidate for ADHD Treatment May Be Associated With Low BMI
Methylphenidate (MPH) use in boys with attention-deficit/hyperactivity disorder (ADHD) appears to be associated with low body mass index (BMI), according to data published in BMC Psychiatry. However, this effect appeared to change based on age bracket and/or duration of MPH use. No evidence was found to confirm the association of MPH with short stature or changes in blood pressure.